India to fund capacity boost at Serum Institute as vaccines run short

19/4/2021 19:31

        India is set to accept the Serum Institute of India's (SII) request for a 30 billion rupee ($400 million) grant to boost its capacity to make the AstraZeneca COVID-19 vaccine, a government source with knowledge of the matter told Reuters.
        
        SII, the world's biggest vaccine maker, sought the funds to increase its monthly capacity to more than 100 million doses by the end of May, from up to 70 million currently.
        
        The country has administered more than 112 million doses of the shot so far, the highest in the world, despite concerns about some people overseas developing blood clots after receiving the vaccine.